A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK. (2020)
Attributed to:
Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.16390
PubMed Identifier: 32077091
Publication URI: http://europepmc.org/abstract/MED/32077091
Type: Journal Article/Review
Volume: 188
Parent Publication: British journal of haematology
Issue: 6
ISSN: 0007-1048